Ignite Creation Date:
2024-05-06 @ 2:49 AM
Last Modification Date:
2024-10-26 @ 11:23 AM
Study NCT ID:
NCT02130193
Status:
COMPLETED
Last Update Posted:
2017-07-02
First Post:
2013-12-19
Brief Title:
Investigation of Safety Tolerability Pharmacokinetics Pharmacodynamics and Clinical Efficacy of Oral Danirixin in Symptomatic COPD Subjects With Mild to Moderate Airflow Limitation at Risk for Exacerbations
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-02-13
Start Date Type:
ACTUAL
Primary Completion Date:
2016-08-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-08-29
Completion Date Type:
ACTUAL
First Submit Date:
2013-12-19
First Submit QC Date:
May 1 2014
Study First Post Date:
2014-05-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2017-05-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-13
Last Update Post Date:
2017-07-02
Last Update Post Date Type:
ACTUAL